Innovative drugs

Sartar exploits principles of precision medicine, drug repurposing and reformulation to provide efficacious cancer therapies faster to the global markets.

A unique academic discovery pipeline to identify novel therapeutic agents acting on human cancer cells.

Repurposing and reformulation enable fast, cost-effective and de-risked development of the first-in-class therapeutics for specific subgroups of sarcomas.

As a group of rare and very rare cancers, sarcomas provide many opportunities for a fast-track regulatory path using the orphan designation.